Home
Company
About us
Our Network
Our Team
Our Governance
Careers
Contact
Expertise
Personalize My Treatment (PMT)
Clinical Operations
Translational Operations
News
News
Publications
Newsletter
Français
Home
Company
About us
Our Network
Our Team
Our Governance
Careers
Contact
Expertise
Personalize My Treatment (PMT)
Clinical Operations
Translational Operations
News
News
Publications
Newsletter
Français
Day
February 7, 2020
07
Feb
Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibition
7 February 2020
admin
Publications
Authors: Mathilde Couëtoux du Tertre, Maud Marques, Suzan McNamara, Karen Gambaro, Cyrla Hoffert, Lise Tremblay, Nicole Bouchard, Razvan Diaconescu, Normand Blais, Christian Couture, Vincent Pelsser, Hangjun Wang, Laura McIntosh, Valérie Hindie, Stephane Parent, Laetitia Cortes, Yannick-André Breton, Gwenael Pottiez, Pascal Croteau, Valerie Higenell, Luisa Izzi, Alan Spatz, Victor Cohen, Gerald Batist & Jason Agulnik Abstract...
Read More
Recent Posts
New CEO Appointment
Exactis, in top clinical trial companies based in Canada
Newsletter #11 – May 5, 2021
Exactis’ is pleased to announce their latest publication in Clinical and Translational Medicine entitled “Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer”.
Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer